4|22|2010 Therapeutic Proteins Inc. Completes First Independent, Dedicated Biosimilars Manufacturing Facility in U.S.
Therapeutic Proteins Inc. (TPI) today announced the completion of the nation's first independent, dedicated, follow-on biologics (or biosimilars) manufacturing facility constructed to meet U.S. Food and Drug Administration (FDA) requirements. The Chicago facility is located at University Technology Park at IIT (Illinois Institute of Technology).
> more